Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yui Takizawa
Canagliflozin as an Initial Therapy in Drug-Naïve Subjects With Type 2 Diabetes Mellitus: A Potential Involvement of Atherogenic Lipids in Its Glycemic Efficacy
Drugs in R and D
Pharmacology
Related publications
Initial Sulfonylurea Use and Subsequent Insulin Therapy in Older Subjects With Type 2 Diabetes Mellitus
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Glycemic Control in Type 2 Diabetes Mellitus Patients
Chattagram Maa-O-Shishu Hospital Medical College Journal
Prehypertension Increases the Risk of Atherosclerosis in Drug-Naïve Japanese Patients With Type 2 Diabetes Mellitus
PLoS ONE
Multidisciplinary
The Cost-Effectiveness of Canagliflozin Versus Sitagliptin as Third-Line Therapy in Type 2 Diabetes Mellitus (T2dm) in a Canadian Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Receiving Insulin-Based Therapy
Archives of Internal Medicine
Efficacy and Safety of Canagliflozin Compared With Placebo in Older Patients With Type 2 Diabetes Mellitus: A Pooled Analysis of Clinical Studies
BMC Endocrine Disorders
Medicine
Endocrinology
Metabolism
Diabetes
Effect of Canagliflozin on Serum Uric Acid in Patients With Type 2 Diabetes Mellitus
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Canagliflozin: Effects in Overweight and Obese Subjects Without Diabetes Mellitus
Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients With Type 2 Diabetes Mellitus
Advances in Therapy
Medicine
Pharmacology
